# Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

> **NCT00787371** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 69 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Hepatitis C

## Interventions

- **BIOLOGICAL:** PegIntron (peginterferon alfa-2b)
- **BIOLOGICAL:** PegIntron (peginterferon alfa-2b)
- **BIOLOGICAL:** PegIntron (peginterferon alfa-2b)

## Key facts

- **NCT ID:** NCT00787371
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787371, "Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00787371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*